
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell... ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.26 | -20 | 1.3 | 1.34 | 0.9802 | 1013751 | 1.09291926 | CS |
4 | -0.66 | -38.8235294118 | 1.7 | 1.75 | 0.9802 | 525474 | 1.30407775 | CS |
12 | -1.01 | -49.2682926829 | 2.05 | 2.09 | 0.9802 | 499885 | 1.54176039 | CS |
26 | -1.3 | -55.5555555556 | 2.34 | 2.57 | 0.9802 | 598619 | 1.89315936 | CS |
52 | -0.75 | -41.8994413408 | 1.79 | 4.44 | 0.9802 | 662295 | 2.2584702 | CS |
156 | -8.36 | -88.9361702128 | 9.4 | 14.19 | 0.9802 | 478226 | 3.64374673 | CS |
260 | -8.36 | -88.9361702128 | 9.4 | 14.19 | 0.9802 | 478226 | 3.64374673 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約